Documentation Centre

 

 

  of 1939 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Associations of dietary cholesterol, serum cholesterol, and egg consumption with overall and cause-specific mortality: systematic review and updated meta-analysis. Circulation. 2022;145:1506-1520 September 19, 2022 Associations of dietary cholesterol, serum cholesterol, and egg consumption with overall and cause-specific mortality: systematic review and updated meta-analysis. Circulation. 2022;145:1506-1520 Zhao B, Gan L, Graubard BI, Männistö S, Albanes D, Huang J Key Publications
What eggsactly are we asking here? Unscrambling the epidemiology of eggs, cholesterol, and mortality. Circulation. 2022;145:1521-1523 September 19, 2022 What eggsactly are we asking here? Unscrambling the epidemiology of eggs, cholesterol, and mortality. Circulation. 2022;145:1521-1523 Tobias DK Key Publications
CENIT (Impact of Cardiac Exercise Training on Lipid Content in Coronary Atheromatous Plaques Evaluated by Near-Infrared Spectroscopy): A randomized trial. J Am Heart Assoc. 2022;11:e024705 September 16, 2022 CENIT (Impact of Cardiac Exercise Training on Lipid Content in Coronary Atheromatous Plaques Evaluated by Near-Infrared Spectroscopy): A randomized trial. J Am Heart Assoc. 2022;11:e024705 Vesterbekkmo EK, Madssen E, Aamot Aksetøy IL, Follestad T, Nilsen HO, Hegbom K, Wisløff U, Wiseth R Key Publications
Exercise intensity and coronary plaque composition: is harder, better, faster, stronger? J Am Heart Assoc. 2022;11:e025991 September 16, 2022 Exercise intensity and coronary plaque composition: is harder, better, faster, stronger? J Am Heart Assoc. 2022;11:e025991 Guseh JS, Jang IK Key Publications
How should public health recommendations address Lp(a) measurement, a causative risk factor for cardiovascular disease (CVD)? Atherosclerosis. 2022;349:136-143 September 15, 2022 How should public health recommendations address Lp(a) measurement, a causative risk factor for cardiovascular disease (CVD)? Atherosclerosis. 2022;349:136-143 Catapano AL, Daccord M, Damato E, Humphries SE, Neely RDG, Nordestgaard BG, Pistollato M, Steinhagen-Thiessen E Key Publications
Lipoprotein(a) and cardiovascular and valvular diseases: A genetic epidemiological perspective. Atherosclerosis. 2022;349:7-16 September 14, 2022 Lipoprotein(a) and cardiovascular and valvular diseases: A genetic epidemiological perspective. Atherosclerosis. 2022;349:7-16 Arsenault BJ, Kamstrup PR. Key Publications
Lipoprotein (a) and diabetes mellitus. Atherosclerosis. 2022;349:63-71 September 14, 2022 Lipoprotein (a) and diabetes mellitus. Atherosclerosis. 2022;349:63-71 Lamina C, Ward NC Key Publications
Non-genetic influences on lipoprotein(a) concentrations. Atherosclerosis. 2022;349:53-62 September 14, 2022 Non-genetic influences on lipoprotein(a) concentrations. Atherosclerosis. 2022;349:53-62 Enkhmaa B, Berglund L Key Publications
Importance of carbohydrate quality: what does it mean and how to measure it? J Nutr. 2022;152:1200-1206 September 06, 2022 Importance of carbohydrate quality: what does it mean and how to measure it? J Nutr. 2022;152:1200-1206 Campos V, Tappy L, Bally L, Sievenpiper JL, Lê KA Key Publications
Optimizing dyslipidemic cardiovascular residual risk reduction with icosapent ethyl in post-mi patients. J Am Coll Cardiol. 2022;79:1672-1674 August 30, 2022 Optimizing dyslipidemic cardiovascular residual risk reduction with icosapent ethyl in post-mi patients. J Am Coll Cardiol. 2022;79:1672-1674 Boden WE, Andersson C Key Publications

  of 1939 Next page

Go to page: of